← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2011Last known activity
Mar 1, 2021
Timeline
2000s
- Jun 1, 2006
DCPrime BV— Founded
2020s
- Dec 21, 2020
Immunicum AB— Acquired
Drugs by trial phase (6 distinct, 8 trials)
Phase 2 (1 own, 4 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (3)
- NCT04739527CollaboratorPhase 1Mar 1, 2021
- NCT03697707Lead sponsorPhase 2Oct 15, 2018
- NCT01373515Lead sponsorPhase 1/Phase 2Apr 1, 2011
Details
- Founded
- Leiden, NL Jun 1, 2006
- Last known activity
- Mar 1, 2021